![]() | |
Legal status | |
---|---|
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
UNII | |
Chemical and physical data | |
Formula | C25H29ClO6 |
Molar mass | 460.95 g·mol−1 |
3D model (JSmol) | |
| |
|
Janagliflozin is an SGLT2 inhibitor developed by Sihuan Pharmaceutical. [1] [2] [3] [4] [5] [6] It is approved in China for the treatment of type 2 diabetes. [7]